valproic acid has been researched along with Cronkhite-Canada Syndrome in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Cronkhite-Canada Syndrome: A nonfamilial polyposis syndrome that is characterized by the presence of diffuse gastrointestinal polyposis, DIARRHEA, and PROTEIN-LOSING ENTEROPATHY. It was first reported by Cronkhite and Canada in 1955.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langlands, AJ | 1 |
| Carroll, TD | 1 |
| Chen, Y | 1 |
| Näthke, I | 1 |
1 other study available for valproic acid and Cronkhite-Canada Syndrome
| Article | Year |
|---|---|
Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells.
Topics: Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; G | 2018 |